Skip to content

Question-based Drug Development for psilocybin - Authors' reply.

Robin L Carhart-Harris, David J Nutt

Lancet Psychiatry September 1, 2016 DOI: 10.1016/s2215-0366(16)30217-6 via PubMed

Study at a glance

Characteristics Peer reviewed
Keywords Psychedelic therapy:psilocybin therapy Psychedelic medicine Therapeutic psychedelics Novel therapies Mental health treatment
Citations 1
Key finding The authors address questions and comments regarding their approach to drug development for psilocybin.

Abstract

Question-based Drug Development for psilocybin - Authors' reply.

Comments

No comments yet.

Log in to comment